Sinclair signs first agreement for distribution and manufacture in India
Speciality pharmaceutical company Sinclair Pharma, of Godalming in the UK, has concluded its first marketing distribution agreement in India.
Speciality pharmaceutical company Sinclair Pharma, of Godalming in the UK, has concluded its first marketing distribution agreement in India.
The 10-year agreement has been signed with Wockhardt, an Indian pharmaceutical and biotech company employing 7,500 people and sales last year of around US$670m (Euro 425m).
It initially covers the following products: Atopiclair non steroidal cream for atopic dermatitis; Aloclair presentations for the treatment of mouth ulcers; Papulex presentations for the treatment of acne; and Decapinol product range for the treatment and prevention of gingivitis and plaque.
Under the agreement Sinclair will provide finished product to Wockhardt but will switch to local manufacture as soon as possible, which will enhance the margins for Sinclair.
"Wockhardt is a dynamic and rapidly growing company and we hope this is the first step towards forging a long-term and mutually rewarding relationship," said Dr Michael Flynn, ceo of Sinclair Pharma
